Connie R Jiménez Selected Research

Connie R Jiménez Research Topics

Disease

21	Neoplasms (Cancer) 04/2024 - 02/2009
4	Colorectal Neoplasms (Colorectal Cancer) 02/2021 - 01/2014
2	Adenocarcinoma 04/2024 - 01/2023
2	Carcinogenesis 09/2022 - 08/2010
2	Tuberculosis (Tuberculoses) 10/2016 - 09/2014
1	Rupture 12/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Ciliopathies 10/2019
1	Chronic Renal Insufficiency 10/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2016
1	Inflammation (Inflammations) 02/2016
1	Latent Infection 02/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2014
1	Adenoma (Adenomas) 05/2014
1	Chromosomal Instability (Chromosome Stability) 05/2014
1	Microsatellite Instability 05/2014
1	Carcinoma (Carcinomatosis) 05/2014
1	Breast Neoplasms (Breast Cancer) 05/2013
1	Pathologic Processes 05/2013
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2013
1	Infections 03/2010
1	Atherosclerosis 02/2009

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 10/2019 - 02/2009
6	Phosphotransferases (Kinase)IBA 04/2024 - 08/2010
5	Tyrosine Kinase InhibitorsIBA 01/2022 - 09/2015
5	Biomarkers (Surrogate Marker)IBA 02/2020 - 04/2010
4	Sunitinib (Sutent)FDA Link 01/2022 - 06/2016
3	ProteomeIBA 04/2024 - 02/2009
3	PhosphopeptidesIBA 01/2022 - 01/2017
3	Peptides (Polypeptides)IBA 02/2021 - 10/2014
2	EnzymesIBA 04/2024 - 08/2010
2	RNA (Ribonucleic Acid)IBA 01/2023 - 02/2016
2	Type VII Secretion SystemsIBA 12/2022 - 10/2016
2	PhosphotyrosineIBA 01/2022 - 01/2017
2	Protein Kinase InhibitorsIBA 02/2021 - 02/2020
2	Sorafenib (BAY 43-9006)FDA Link 02/2020 - 12/2016
2	Tyrosine (L-Tyrosine)FDA Link 02/2020 - 06/2016
2	Dasatinib (BMS 354825)FDA Link 02/2020 - 12/2016
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2020 - 12/2016
2	CytokinesIBA 01/2019 - 03/2010
1	Histones (Histone)IBA 04/2024
1	Drug CombinationsIBA 01/2023
1	serum P-component (CIt)IBA 02/2021
1	Protein Kinases (Protein Kinase)IBA 02/2021
1	amsonic acid (DAS)IBA 02/2020
1	VemurafenibIBA 02/2020
1	Everolimus FDA Link 02/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2016
1	DNA (Deoxyribonucleic Acid)IBA 02/2016
1	MicroRNAs (MicroRNA)IBA 02/2016
1	Epstein-Barr virus encoded RNA 1IBA 02/2016
1	Small Interfering RNA (siRNA)IBA 06/2015
1	AntigensIBA 09/2014
1	Membrane Proteins (Integral Membrane Proteins)IBA 09/2014
1	EpitopesIBA 09/2014
1	Prion ProteinsIBA 06/2014
1	Amyloid (Amyloid Fibrils)IBA 06/2014
1	Nuclear Proteins (Protein, Nuclear)IBA 05/2014
1	Carrier Proteins (Binding Protein)IBA 05/2014
1	ChromatinIBA 05/2014
1	Conditioned Culture MediaIBA 11/2013
1	Estrogens (Estrogen)FDA Link 05/2013
1	Estrogen Receptor Modulators (Antiestrogen)IBA 05/2013
1	Hormones (Hormone)IBA 05/2013
1	Aromatase InhibitorsIBA 05/2013
1	Estrogen Receptor alphaIBA 05/2013
1	ParaffinIBA 04/2013
1	Formaldehyde (Formol)FDA Link 04/2013
1	trans-crotonin (CTN)IBA 01/2013
1	OsteopontinIBA 04/2010
1	Capsules (Microcapsules)IBA 03/2010

Therapy/Procedure

6	Therapeutics 04/2024 - 08/2010
1	Immunotherapy 01/2019
1	Precision Medicine 01/2017
1	Radiotherapy 06/2015
1	Lasers (Laser) 10/2014